Could a Type 2 Diabetes Drug Tackle Kidney Stones? Could a Type 2 Diabetes Drug Tackle Kidney Stones?
A pooled data analysis of trials of the SGLT2 inhibitor empagliflozin in type 2 diabetes suggests it may lower the risk of kidney stones. However, this is early research.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Nephrology News Source Type: news
More News: Diabetes | Diabetes Type 2 | Empagliflozin | Endocrinology | Jardiance | Kidney Stones | Primary Care | SGLT2 Inhibitors | Urology & Nephrology